infirst Healthcare in the press
All our press releases are in PDF format and will open in a new window.
-
Flarin’s Philip Lindsell: UK ITV Backing Could Provide Springboard For International Expansion 14 September 2023 Flarin Holdings recently secured £5m ($6.2m) investment from UK television company ITV's Media for Equity fund in return for a minority stake in the company, which markets analgesic brand Flarin in the UK. The investment could be a springboard for international expansion, including in the US, Flarin's managing director Philip Lindsell tells HBW Insight in an exclusive in-depth interview. View the press release
-
Flarin to boost advertising with major fundraising
16 August 2023
Joint pain relief brand Flarin® is pleased to announce that it has received major investments from ITV as part of its Media for Equity portfolio and through existing investor IW Capital.
ITV’s Media for Equity investment fund, ITV AdVentures, has agreed to invest up to £5 million of advertising inventory across ITV’s channels in return for a minority equity stake in the company. Flarin® is its first consumer healthcare investment to date. In addition, IW Capital has agreed to invest up to £1.825 million alongside ITV in this round and this follows their previous equity investments of £8.7 million in the company. The first tranche of both new investments was completed 15th August 2023.
View the press release
-
Flarin Holdings appoints CTH to drive globalisation of the world’s first lipid formulated ibuprofen 17 October 2022 Flarin Holdings Limited (FHL), trading through its subsidiary Infirst Limited, today announces that it has appointed Capel Thompson & Homer LLP (CTH) as advisor to assist in seeking a licensing partner for its patented lipid NSAID technology in the USA and other geographies. View the press release
-
Flarin™, fastest growing adult analgesic in the UK is listed in Tesco
01 April 2022
Infirst Limited is pleased to announce that it has recently reached agreement with Tesco for the listing of its lipid formulated painkiller Flarin™ Joint and Muscular Pain Relief across
stores. This adds to the existing listing of the larger 30 count pack already available in Tesco pharmacies. This new roll-out of the Flarin product follows a period of sustained growth for Flarin™ since its launch in 2018.
View the press release
-
Flarin Holdings completes oversubscribed second round of fundraising 06 April 2021 Flarin Holdings Limited (FHL), trading under the name Infirst Limited, today announces the completion of its second fund-raising round.
Following its initial investment in 2019, IW Capital again led the funding to support the exciting development of this fast-growing business.
Over the past year Flarin has seen expansion through sales of Flarin Joint and Muscular Pain Relief into mass multiples such as Boots, Superdrug, Sainsbury, Morrisons as well as Amazon, Ocado and other online retailers. View the press release
-
FLARIN (lipid-formulated ibuprofen) introduces
FLARIN JOINT & MUSCULAR PAIN RELIEF 15 July 2020 Infirst Ltd announces that the Flarin brand range will be expanding with the launch of Flarin Joint & Muscular Pain Relief from July 2020. Flarin Joint & Muscular Pain Relief, which has a GSL licence, will be available for consumers to self-select from the pain relief aisle. View the press release -
Flarin to be trialled in COVID-19 patients 03 June 2020 Infirst Limited, a privately-owned UK healthcare company focused on improving existing medicines, today confirms that its flagship product Flarin is to be tested as a treatment for certain symptoms of hospitalised COVID-19 patients. View the press release
-
Flarin Holdings completes first round of fundraising to drive rapid commercialisation of world’s first lipid formulated ibuprofen
04 November 2019
Flarin Holdings Limited today announces the completion of its first round of fund-raising by IW Capital. Flarin Holdings was recently demerged from Infirst Healthcare Limited in order to provide greater focus on the rapid commercialisation of Flarin.
View the press release
-
Infirst Healthcare Group demerges to accelerate growth of its businesses 30 October 2019 Infirst Healthcare Limited, a privately-owned UK healthcare company focused on improving existing medicines, today announces that it has demerged into three separate companies in order to accelerate growth of these separate businesses: View the press release
-
"Innovation of the Year - 2019 Winner CHI Awards" 28 February 2019 Infirst Healthcare’s Flarin is the winner of the CHi Award for Innovation of the Year, with one judge describing the medicine for flaring joint pain and inflammation as a “potential game changer". View the press release
1
year wait
The average Briton waits a YEAR before visiting their GP about apparently minor health issues